Checkout our iOS App for a better way to browser and research.
(1) "Approved study" means a medical research study:
(a) the purpose of which is to investigate the medical benefits and risks of cannabinoid products; and
(b) that is approved by an IRB.
(2) "Board" means the Cannabinoid Product Board created in Section 26-61-201.
(3) "Cannabinoid product" means the same as that term is defined in Section 58-37-3.6.
(4) "Cannabis" means the same as that term is defined in Section 58-37-3.6.
(5) "Expanded cannabinoid product" means the same as that term is defined in Section 58-37-3.6.
(6) "Institutional review board" or "IRB" means an institutional review board that is registered for human subject research by the United States Department of Health and Human Services.
Technically renumbered to avoid duplication of section number also enacted in HB345, Chapter 413.